BlueShield Extends Coverage of Coronavirus Treatment
To ensure members continue to have access to the care they need during the COVID-19 pandemic, BlueShield of Northeastern New York will continue to waive all copays, coinsurance and deductibles for COVID-19 treatment received by fully insured Commercial and Medicare Advantage members through June 30, an extension from the original announcement that was set to end May 31, 2020.
All Member Out-of-Pocket Costs Waived for Coronavirus Testing and Treatment
In light of these unprecedented times, we are announcing that BlueShield of Northeastern New York is eliminating any and all costs for our members related to COVID-19 testing and treatment. This includes our Medicare Advantage and fully insured Commercial members. No co-pays, no cost-shares, no-coinsurance on the part of our members will be required effective April 1 through May 31, 2020. This includes any testing, care or treatment provided anywhere in the United States for our members.
BlueShield of Northeastern New York will Cover Cost of Testing, Help Prevent the Spread and Impact of COVID-19
Amid the growing concerns about the spread of the COVID-19 in communities across the country, BlueShield of Northeastern New York has announced the following immediate updates to help prevent the spread and impact of COVID-19.
BlueShield of Northeastern New York’s Blue Fund is now accepting letters of intent online through March 27, 2020, for grants to organizations and initiatives that align with at least one of its key focus areas. These include behavioral health, cardiovascular health, health-care workforce development, and healthy children.
BlueShield of Northeastern New York is following the guidelines of the Centers for Disease Control and Prevention for the novel coronavirus. The emerging, rapidly evolving situation was first detected in Wuhan City, China and now has been detected in 50 locations internationally, including cases in the United States.
The World Health Organization (WHO) declared the new coronavirus outbreak a public health emergency of international concern Thursday, January 30. The New York State Department of Health (NYSDOH), the Centers for Disease Control (CDC), and our local public health officials are closely following the novel coronavirus (2019-nCoV).
BlueShield of Northeastern New York Announces Partnership with Civica Rx
BlueShield of Northeastern New York, in partnership with 18 independent and locally-operated Blue Cross and Blue Shield (BCBS) companies throughout the country and the Blue Cross Blue Shield Association (BCBSA), announced a partnership with nonprofit generic drug company, Civica RX, to create a subsidiary dedicated to lowering the cost of select generic drugs.